AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33511816 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE prescribed and self‐regulated by RPE (HIIE<inf>RPE</inf>)
Number of subjects: 12
Study 33511816 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE prescribed and regulated by HR response to cardiopulmonary exercise test (HIIE<inf>HR</inf>)
Number of subjects: 12
Study 33511816 — intervention group
Group type: COMPARATOR
Intervention: Control session (25 minutes of seated resting)
Number of subjects: 12
Study 33852958 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-varying CPR (TVCPR), alternating between 100 and 200 compressions per minute (cpm) every 6 seconds
Number of subjects: 20
Study 33852958 — intervention group
Group type: COMPARATOR
Intervention: Control (guidelines CPR)
Number of subjects: 20
Study 32179502 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Intelligence Training based on Bar-On Combined Model, provided in eight 90-minute sessions for eight weeks.
Number of subjects: 70
Study 32179502 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 70
Study 35906688 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic cigarette
Number of subjects: 11
Study 35906688 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated tobacco product
Number of subjects: 11
Study 33334571 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303
Study 33334571 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303
Study 34332374 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in Affect Recognition (TAR)
Number of subjects: 100
Study 34332374 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognition and Interaction Training (SCIT)
Number of subjects: 100
Study 34332374 — intervention group
Group type: COMPARATOR
Intervention: Both TAR and SCIT
Number of subjects: 100
Study 33083487 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep cervical flexor (DCF) training and postural education
Number of subjects: 30
Study 33083487 — intervention group
Group type: COMPARATOR
Intervention: Postural education only
Number of subjects: 30
Study 32552074 — intervention group
Group type: EXPERIMENTAL
Intervention: FindMyApps training and selection tool
Number of subjects: 20
Study 32552074 — intervention group
Group type: COMPARATOR
Intervention: Short tablet training (Control)
Number of subjects: 20
Study 34118123 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of dexketoprofen
Number of subjects: 200
Study 34118123 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg of paracetamol
Number of subjects: 200
Study 35933133 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate TR
Number of subjects: 13068
Study 35933133 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-severe TR
Number of subjects: 13068
Study 35933133 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe TR
Number of subjects: 13068
Study 35933133 — intervention group
Group type: EXPERIMENTAL
Intervention: TRIO score
Number of subjects: 13068
Study 32011589 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental risk-reduction behaviors (private well testing, radon screening, CO detector ownership)
Number of subjects: 1000
Study 32011589 — intervention group
Group type: EXPERIMENTAL
Intervention: CO detector ownership and radon screening
Number of subjects: 1000
Study 32011589 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors (white or Asian, college-educated, earn more than $50,000, own homes)
Number of subjects: 1000
Study 32011589 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1000
Study 34855098 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS) services
Number of subjects: 0
Study 32719073 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 229
Study 35988205 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-loaded nanoparticles
Number of subjects: 88
Study 35988205 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 88
Study 33619220 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care (EPC)
Number of subjects: 157
Study 33619220 — intervention group
Group type: EXPERIMENTAL
Intervention: EPC + inpatient palliative care unit (PCU)
Number of subjects: 157
Study 33619220 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EPC)
Number of subjects: 157
Study 32917223 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency model assessment scale for family physicians
Number of subjects: 0
Study 35781594 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine for 6 weeks
Number of subjects: 38
Study 35781594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: General public awareness of malaria
Number of subjects: 262
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of transmission routes
Number of subjects: 262
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking health advice or treatment
Number of subjects: 262
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for malaria
Number of subjects: 262
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: Demand for long-lasting insecticidal nets
Number of subjects: 262
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortage of long-lasting insecticidal nets
Number of subjects: 262
Study 33816430 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with children under 5 lacking nets
Number of subjects: 262
Study 35123290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT) for 12 weeks
Number of subjects: 40
Study 35123290 — intervention group
Group type: COMPARATOR
Intervention: Facilitated peer support (FPS)
Number of subjects: 40
Study 35123290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 40
Study 33617699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10 weekly sessions
Number of subjects: 48
Study 33617699 — intervention group
Group type: COMPARATOR
Intervention: Clinical Monitoring Only (CMO)
Number of subjects: 48
Study 33617699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 48
Study 36232205 — intervention group
Group type: EXPERIMENTAL
Intervention: CHoBI7 Cholera Rapid Response Program
Number of subjects: 284
Study 36232205 — intervention group
Group type: COMPARATOR
Intervention: Standard message on oral rehydration solution
Number of subjects: 284
Study 34636752 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine (1.5 mg/kg bolus of 1% lidocaine after anesthesia induction followed by a continuous infusion of 2 mg/kg/h up to 1 h after surgery)
Number of subjects: 90
Study 34636752 — intervention group
Group type: COMPARATOR
Intervention: Saline (equal volume to lidocaine)
Number of subjects: 90
Study 34636752 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine
Number of subjects: 90
Study 34636752 — intervention group
Group type: COMPARATOR
Intervention: IV lidocaine and saline
Number of subjects: 90
Study 35272094 — intervention group
Group type: EXPERIMENTAL
Intervention: rmPFC iTBS
Number of subjects: 35
Study 35272094 — intervention group
Group type: COMPARATOR
Intervention: Control iTBS
Number of subjects: 35
Study 34773971 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized invitation letters
Number of subjects: 1511
Study 34773971 — intervention group
Group type: COMPARATOR
Intervention: Generic invitation letters
Number of subjects: 1511
Study 32566980 — intervention group
Group type: EXPERIMENTAL
Intervention: IPFP preservation
Number of subjects: 42
Study 32566980 — intervention group
Group type: COMPARATOR
Intervention: IPFP resection
Number of subjects: 42
Study 35477430 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective corrective exercises (SCEs) for 8 weeks
Number of subjects: 103
Study 35477430 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study 34032710 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy plus adjuvant gemcitabine plus cisplatin
Number of subjects: 50
Study 34032710 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy plus adjuvant 5-fluorouracil plus cisplatin
Number of subjects: 50
Study 34959205 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-positive & RCT-positive individuals (86% ACC/AHA, 88% CCS, 88% NICE, 84% ESC/EAS)
Number of subjects: 79171
Study 34959205 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-positive & RCT-negative individuals (5-7%)
Number of subjects: 79171
Study 34959205 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-negative & RCT-positive individuals (28-39%)
Number of subjects: 79171
Study 34959205 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-negative & RCT-negative individuals (30-31%)
Number of subjects: 79171
Study 34959205 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity statin therapy
Number of subjects: 79171
Study 32591573 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger-diameter screws (6.5 mm × 45 mm) and longer screws (6.0 mm × 50 mm) in the normal-density group
Number of subjects: 60
Study 32591573 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer screws (6.0 mm × 50 mm) in the osteoporosis group
Number of subjects: 60
Study 32591573 — intervention group
Group type: COMPARATOR
Intervention: Normal-density group
Number of subjects: 60
Study 32591573 — intervention group
Group type: COMPARATOR
Intervention: Osteoporosis group
Number of subjects: 60
Study 33606179 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation for primary prevention
Number of subjects: 177
Study 33606179 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 177
Study 35275991 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg twice daily
Number of subjects: 303
Study 35275991 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 303
Study 34130883 — intervention group
Group type: COMPARATOR
Intervention: Moderna vaccine (1 dose)
Number of subjects: 0
Study 32280035 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality foster care intervention
Number of subjects: 136
Study 32280035 — intervention group
Group type: COMPARATOR
Intervention: Institutional rearing (neglect)
Number of subjects: 136
Study 34534511 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir plus standard of care
Number of subjects: 857
Study 34534511 — intervention group
Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 857
Study 32871620 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) filling
Number of subjects: 40
Study 32871620 — intervention group
Group type: COMPARATOR
Intervention: Saline filling
Number of subjects: 40
Study 35675092 — intervention group
Group type: EXPERIMENTAL
Intervention: External vein graft support
Number of subjects: 224
Study 35675092 — intervention group
Group type: COMPARATOR
Intervention: No support
Number of subjects: 224
Study 32369436 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial knee replacement
Number of subjects: 528
Study 32369436 — intervention group
Group type: COMPARATOR
Intervention: Total knee replacement
Number of subjects: 528
Study 36383926 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary Lymph Node Dissection (ALND)
Number of subjects: 1425
Study 36383926 — intervention group
Group type: COMPARATOR
Intervention: Axillary Radiotherapy (ART)
Number of subjects: 1425
Study 34398956 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r 400 mg/100 mg twice daily + RBT 150 mg/day (Arm A)
Number of subjects: 71
Study 34398956 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r 800 mg/200 mg twice daily + RIF 600 mg/day (Arm B)
Number of subjects: 71
Study 34398956 — intervention group
Group type: EXPERIMENTAL
Intervention: LPV/r 400 mg/100 mg twice daily + RAL 400 mg twice daily + RBT 150 mg/day (Arm C)
Number of subjects: 71
Study 32423396 — intervention group
Group type: EXPERIMENTAL
Intervention: Journal therapy counseling (3 in-person sessions and 3 telephone sessions)
Number of subjects: 70
Study 32423396 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 70
Study 34773292 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 25 mg/d
Number of subjects: 100
Study 34773292 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 50 mg/d
Number of subjects: 100
Study 34921525 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 92
Study 34705578 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 292
Study 34705578 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 292
Study 34705578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study 32210157 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs)
Number of subjects: 73
Study 32210157 — intervention group
Group type: COMPARATOR
Intervention: No treatment (reference group)
Number of subjects: 73
Study 35976944 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (1000 μg MK‐7/day)
Number of subjects: 44
Study 35976944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 34780632 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated bidet intervention
Number of subjects: 10
Study 33394994 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Intelligence (AI) support system
Number of subjects: 200
Study 33394994 — intervention group
Group type: COMPARATOR
Intervention: Pooled reader assessment
Number of subjects: 200
Study 34198444 — intervention group
Group type: EXPERIMENTAL
Intervention: GA-BPNN (Genetic Algorithm optimized Back Propagation Neural Network)
Number of subjects: 80
Study 34198444 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods (subjective prediction based on routine ultrasound and physical examination)
Number of subjects: 80
Study 36152526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic exercise program (bike group), 45 minutes per session, 3 times/week for 3 months.
Number of subjects: 18
Study 32560932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 25
Study 32560932 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.045 mg/kg)
Number of subjects: 25
Study 34735762 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanesthetic IV ketamine (0.3 mg/kg)
Number of subjects: 141
Study 34735762 — intervention group
Group type: COMPARATOR
Intervention: Caudal 0.125% bupivacaine (1 ml/kg)
Number of subjects: 141
Study 34735762 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanesthetic IV ketamine
Number of subjects: 141
Study 34735762 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanesthetic IV ketamine and Caudal bupivacaine
Number of subjects: 141
Study 35010482 — intervention group
Group type: EXPERIMENTAL
Intervention: I-Walk training
Number of subjects: 30
Study 35010482 — intervention group
Group type: COMPARATOR
Intervention: Overground gait training (control)
Number of subjects: 30
Study 34776421 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory stimulation during 2-week task-practice therapy
Number of subjects: 12
Study 34776421 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (control group) during 2-week task-practice therapy
Number of subjects: 12
Study 34551995 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrasentan 0.75 mg/day
Number of subjects: 0
Study 34551995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34551995 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrasentan
Number of subjects: 0
Study 35248274 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Treatment (4 treatments over 8 weeks)
Number of subjects: 70
Study 35248274 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no osteopathic treatment)
Number of subjects: 70
Study 34464729 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ProGlide
Number of subjects: 60
Study 34464729 — intervention group
Group type: COMPARATOR
Intervention: Surgical cut-down
Number of subjects: 60
Study 32304514 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 repetition maximum (RM) for 7 sets (4RM)
Number of subjects: 42
Study 32304514 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 repetition maximum (RM) for 4 sets (8RM)
Number of subjects: 42
Study 32304514 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 repetition maximum (RM) for 3 sets (12RM)
Number of subjects: 42
Study 32304514 — intervention group
Group type: COMPARATOR
Intervention: Nonexercising control group (CON)
Number of subjects: 42
Study 34192691 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame powder
Number of subjects: 90
Study 34192691 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (control)
Number of subjects: 90
Study 35012538 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dose group coaching (5 months)
Number of subjects: 72
Study 35012538 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended dose group coaching (5 months + 18 months one-on-one coaching)
Number of subjects: 72
Study 35012538 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dose group coaching with unstructured engagement of scientific advisors
Number of subjects: 72
Study 35012538 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular dose group coaching with structured engagement of scientific advisors
Number of subjects: 72
Study 33279317 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS group (4,225 participants)
Number of subjects: 6338
Study 33279317 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6338
Study 36280185 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanodropper (10.4 μl of eye drops)
Number of subjects: 50
Study 36280185 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC, 50 μl of eye drops)
Number of subjects: 50
Study 33650921 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-intensive exercises for 20 minutes per day, 5 days per week, for 8 weeks
Number of subjects: 64
Study 33650921 — intervention group
Group type: COMPARATOR
Intervention: Non-auditory intensive games for 20 minutes per day, 5 days per week, for 8 weeks
Number of subjects: 64
Study 34402784 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol (150 mg or 300 mg)
Number of subjects: 1714
Study 34402784 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg or 400 mg)
Number of subjects: 1714
Study 34402784 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 1714
Study 34402784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1714
Study 34402784 — intervention group
Group type: COMPARATOR
Intervention: Comparators (solriamfetol, modafinil, armodafinil)
Number of subjects: 1714
Study 33290635 — intervention group
Group type: COMPARATOR
Intervention: Conventional symptomatic treatment (Miconaz oral gel, BBC oral spray)
Number of subjects: 45
Study 33290635 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% chamomile topical oral gel
Number of subjects: 45
Study 33290635 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment + 3% chamomile topical oral gel
Number of subjects: 45
Study 32404040 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioembolic strokes
Number of subjects: 1429
Study 32404040 — intervention group
Group type: COMPARATOR
Intervention: Noncardioembolic strokes
Number of subjects: 1429
Study 36351174 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion
Number of subjects: 0
Study 36351174 — intervention group
Group type: COMPARATOR
Intervention: No sodium bicarbonate infusion (control group)
Number of subjects: 0
Study 33860553 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help intervention (SH)
Number of subjects: 194
Study 33860553 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-care professional discussion (HP)
Number of subjects: 194
Study 33860553 — intervention group
Group type: EXPERIMENTAL
Intervention: Written oncofertility educational resource (ER)
Number of subjects: 194
Study 33860553 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 194
Study 32615462 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 20
Study 32615462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35722108 — intervention group
Group type: EXPERIMENTAL
Intervention: Firehawk stent
Number of subjects: 0
Study 35722108 — intervention group
Group type: COMPARATOR
Intervention: Xience stent
Number of subjects: 0
Study 32372750 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Pasteurization Indicators (WAPIs)
Number of subjects: 28
Study 32372750 — intervention group
Group type: EXPERIMENTAL
Intervention: WAPI with a plastic box that floated on the water's surface
Number of subjects: 28
Study 32372750 — intervention group
Group type: COMPARATOR
Intervention: WAPI with a wire dipped into the pot
Number of subjects: 28
Study 32778902 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanically assisted gait training (Exowalk®)
Number of subjects: 40
Study 32778902 — intervention group
Group type: COMPARATOR
Intervention: Physical therapist‐assisted gait training
Number of subjects: 40
Study 35863693 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 108
Study 35863693 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Training (CT)
Number of subjects: 108
Study 34073203 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid model based on 3D structure of peptides; specific dosage and duration not mentioned.
Number of subjects: 0
Study 34073203 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro experiments with five randomly selected novel ACPs; specific dosage and duration not mentioned.
Number of subjects: 0
Study 32156842 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-curcumin (120 mg) for 12 weeks
Number of subjects: 0
Study 35086229 — intervention group
Group type: EXPERIMENTAL
Intervention: Video counseling
Number of subjects: 60
Study 35086229 — intervention group
Group type: EXPERIMENTAL
Intervention: Chart counseling
Number of subjects: 60
Study 35086229 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal counseling
Number of subjects: 60